Stand Up To Cancer Innovative Research Grants
The Stand Up To Cancer (SU2C), Innovative Research Grant is open to early-career scientists whose novel, high-risk, high-reward cancer research proposals have significant potential for translational application and hold great promise for advancing SU2C's overarching goal of improving and saving the lives of patients. Letters of Intent may focus on any discipline within basic, translational, or clinical cancer research. Projects that are currently supported by NIH R01 grants or the equivalent will not be accepted.
Letters of Intent will be reviewed by the Innovative Research Grant Committee (IRGC). Applicants with the most promising idea submissions will be invited to submit full proposals. The IRGC will make recommendations to the SU2C Scientific Advisory Committee and 10 applicants from the invited proposals will be selected and awarded up to $750,000 over the 3-year term of the grant.
Detailed information is available in the Program Guidelines and Application Instructions.
The SU2C Innovative Research Grants will fund novel, high-risk, high-reward cancer research proposals that have significant potential for translational application and hold great promise for advancing SU2C's overarching goal of improving and saving the lives of patients. Proposals may focus on any discipline within basic, translational, or clinical cancer research, provided that these criteria are met.
Projects that are currently supported by NIH R01 grants or the equivalent will not be accepted.
Tenure-track, independent investigators who have started their first independent position no more than 7 years ago, that is on or after June 30, 2009, are eligible to submit a Letter of Intent. Postdoctoral fellows, clinical research fellows, or any other researchers-in-training who are working under the direction of a scientific mentor are not eligible to apply. Only one letter of intent will be accepted per investigator.
For institutions that do not follow the traditional tenure system, such as non-academic, non-profit research institutions, tenure-track can be interpreted as a stated commitment from the institution of defined space that the applicant controls independent of other staff and defined money over a number of years to support the applicant's research. The nature of the applicant's appointment at the institution in terms of years and salary support must be independent of this or any other grant.
Applicants must have acquired a medical or other doctoral degree. Applicants must be affiliated with an academic, medical, or research institution within the United States. There are no citizenship or residency status restrictions.
Employees or subcontractors of a government institution or for-profit industry are not eligible to apply as Principal Investigators but may be listed as collaborators. No grant funds may be directed to collaborators working within government institutions or for-profit industry. Collaborators are optional. Collaborators are independent researchers who have an integral role in the proposed project. Fellows and Research Assistants working on the project are not considered Collaborators.
Individuals serving as SU2C Dream Team Leaders or Principals are not eligible to apply.
The eligibility checklist must be completed and submitted by all applicants.
Candidates with a question about the eligibility requirements are encouraged to contact the AACR's SRGA at [email protected] prior to submitting the proposal.
None
None
The AACR requires applicants to submit an electronic Letter of Intent by Friday, November 13, 2015 at 12:00 p.m. (noon) ET, using the proposalCENTRAL website at https://proposalcentral.altum.com/
Program Guidelines and Letter of Intent Instructions are available.